Role of matrix metalloprotease-2 and MMP-9 in experimental lung fibrosis in mice

Tina Bormann1, Regina Maus1, Jennifer Stolper1

  • 1Division of Experimental Pneumology, Hannover Medical School, Feodor-Lynen-Strasse 21, 30625, Hannover, Germany.

Abstract

Insights

Matrix metalloproteinases (MMPs), specifically MMP-2 and MMP-9, are elevated in idiopathic pulmonary fibrosis (IPF). However, deleting these gelatinases did not impact experimental lung fibrosis in mice, suggesting a minor role.

Area of Science:

  • Pulmonary Medicine
  • Molecular Biology
  • Biochemistry

Background:

  • Idiopathic pulmonary fibrosis (IPF) is a severe lung disease marked by excessive extracellular matrix (ECM) deposition.
  • Matrix metalloproteinases (MMPs) regulate ECM, but the roles of MMP-2 and MMP-9 in lung fibrosis are unclear.

Purpose of the Study:

  • To investigate the role of MMP-2 and MMP-9 in the development of experimental lung fibrosis.
  • To determine if MMP-2 and MMP-9 contribute to collagen deposition and lung function changes in fibrosis.

Main Methods:

  • Induced lung fibrosis in wild-type, MMP-2 knockout, MMP-9 knockout, and double knockout mice using adenoviral TGF-β1.
  • Assessed lung fibrosis via hydroxyproline assay, lung function tests (FlexiVent), histopathology, Western blot, and ELISA for MMP levels and collagen content.

Main Results:

  • MMP-2 and MMP-9 levels were elevated in IPF lung homogenates and in mice treated with adenoviral TGF-β1.
  • Deletion of MMP-2, MMP-9, or both did not alter the severity of experimental lung fibrosis or lung function.

Conclusions:

  • Gelatinases MMP-2 and MMP-9 appear to play a subordinate role in experimental lung fibrosis.
  • Targeting MMP-2 and MMP-9 may not be an effective strategy for treating lung fibrosis.